Brief: FDA Approves Alcon’S BRYTL Eye Drops
16/10/2026 22:47
BRIEF-FDA Approves Alcon’S BRYTL Eye Drops Oct 16 (Reuters) - Alcon AG ALCC.S:
FDA APPROVES ALCON’S BRYTLY REDNESS RELIEVER EYE DROPS FOR UP TO 12 HOURS OF WHITER, BRIGHTER-LOOKING EYES
Source text: ID:nBw1Bjvnqa
Further company coverage: ALCC.S
((reuters.briefs@thomsonreuters.com;))
Recent news on Alcon AG
See all newsBrief: Alcon Acquires Neurotech And Encelto, The Only FDA-Approved Treatment For Mactel Type 2
Brief: Alcon Acquires Neurotech And Encelto, The Only FDA-Approved Treatment For Mactel Type 2
Swiss stocks - Factors to watch on October 19
Brief: FDA Approves Alcon’S BRYTL Eye Drops
Advisory: Alert incorrectly tagged to Omega Interactive Technologies withdrawn